ALAN KRAVATZ: Open Payments
NPI 1356369623 · LEVITTOWN, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$487 in 22 payments from 9 companies in 2025. Trend: 2023 $794 · 2024 $579 · 2025 $487
Food & beverage: $487
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $170 |
| Novo Nordisk Inc | 4 | $72 |
| PFIZER INC. | 4 | $60 |
| GlaxoSmithKline, LLC. | 3 | $49 |
| Lilly USA, LLC | 2 | $37 |
| Janssen Pharmaceuticals, Inc | 1 | $30 |
| Amgen Inc. | 2 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $21 |
| Exact Sciences Corporation | 1 | $20 |
Products named: FASENRA, SHINGRIX, PREVNAR 20, MOUNJARO, SPRAVATO, OTEZLA, AIRSUPRA, Rybelsus.
Industry payments across PA — which companies pay providers there.
